Catalyst Wire Dossier Catalyst Wire Dossier

Kanarb

Fimasartan · Boryung Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Kanarb, covering 2009-12-24 to 2019-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension [Phase 3]

See pricing